IQuity Labs Raises $2.35 Million

We represented IQuity Labs, a life science tech company, in its second round of seed financing totaling nearly $2.4 million. The capital will be used to open IQuity’s CLIA-certified laboratory in Nashville, Tennessee, and support the launch of IsolateMS – its first diagnostic test and the first RNA-based diagnostic test to detect multiple sclerosis. The investors in this round were not disclosed.

IQuity is a specialty diagnostic technology company leveraging machine learning methods to deliver breakthrough RNA analytics across neurology, gastroenterology and rheumatology.

You Also May Be Interested In:

  • Representation of Family Legacy, LLC and Harpeth Hills Memory Gardens, Inc. in their sale to Park Lawn Corporation (TSX: PLC), a company that provides goods and services associated with the disposition and memorialization of human remains

    We represented Family Legacy, LLC and Harpeth Hills Memory Gardens, Inc. in their sale to Park Lawn Corporation (TSX: PLC),...
    Client Type: Private Company
  • Representation of WellCare Health Plans, Inc., a government-focused managed care provider, in its merger with Centene Corporation (NYSE: CNC) for $17.3 billion

    We represented WellCare Health Plans, Inc. in its merger with Centene Corporation (NYSE: CNC) for $17.3 billion. The combined company...
    Client Type: Public Company
  • Representation of LFM Capital in its sale of EDSCO Fasteners, a leading supplier of foundation anchoring systems for critical infrastructure installations, to MiddleGround Capital

    We represented LFM Capital in its sale of EDSCO Fasteners, a leading supplier of foundation anchoring systems for critical infrastructure...
    Client Type: Private Company